Judy was appointed chair in May 2019. Before this she had had a successful career with the world’s first electronic brokerage firm, Instinet, culminating in a board role leading its European equities division.
In 2003 Judy started treatment for the blood cancer multiple myeloma. Since then she has worked tirelessly to improve the treatment for and care of myeloma patients, chairing the board of Myeloma UK and then becoming its president. Judy is the lead governor at the Royal Free London NHS Foundation Trust (RFL), where she has been treated for many years. She is also a patient representative on various boards and advisory groups.
She said: “I am delighted to be leading the Royal Free Charity as we continue our work to improve the services provided to patients, support the dedicated and hardworking Royal Free staff and fund research.”